Skip to main content
European Commission logo
English English
CORDIS - EU research results
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

MYokinetic Towards Innovation

Project description

Bringing an innovative brain-machine interface to the market

A brain-machine interface (BMI) is a technology that enables direct communication between the brain and an external device, often a prosthetic limb. This interface facilitates the translation of neural activity into commands that can control these devices. Funded by the European Research Council, the MYTI project builds on previously developed BMI technology that uses implanted permanent magnets in muscle to decode muscle contractions and control upper-limb prostheses. The project will optimise technological parameters and magnet implantations while addressing various challenges associated with long-term usability of the BMI. Following extensive clinical trial validation, the team will prepare for commercialisation of the technology.

Objective

MYTI - MYokinetic Towards Innovation, aims at boosting the clinical translation of the technology developed within the ERC funded project MYKI - A Bidirectional MyoKinetic Implanted Interface for Natural Control of Artificial Limbs. Core of the project is an innovative human-machine-interface for the control of upper-limb prostheses, which relies on a multitude of permanent magnets implanted within the residual muscles. Briefly, external electronic components acquire the magnetic field of the magnets, retrieve their displacement resulting from muscle contraction, and subsequently decode the user’s intention to control multiple degrees of freedom of the prosthesis in a natural and intuitive way. The MYKI project led to the successful first-in-human clinical demonstration of the interface: one participant received the short-term (six-week) implantation of multiple magnets and was fitted with a self-contained myokinetic prosthesis. In just six weeks, the participant achieved performance comparable to those achieved with standard-of-care solutions. Building on the know-how acquired within MYKI, MYTI will address the weaknesses uncovered by past research, and push forward the advancement of the solution for its adoption into standard-of-care settings. Practically, it will address the open challenges related to the long-term usability of the interface, to enable extensive long-term clinical trials necessary to validate the technology, while laying the foreground for its future commercialization.
The translation from research towards innovation will be achieved through three main objectives: (i) the identification of a magnet coating material suitable for chronic applications; (ii) the effective insertion of the magnets inside the muscles, through the development of a dedicated surgical injector to be used under ultrasound guidance; (iii) the conduction of an in-depth market research and the definition of an IPR strategy aimed at the future technology commercialization.

Keywords

Host institution

SCUOLA SUPERIORE DI STUDI UNIVERSITARI E DI PERFEZIONAMENTO S ANNA
Net EU contribution
€ 150 000,00
Address
PIAZZA MARTIRI DELLA LIBERTA 33
56127 Pisa
Italy

See on map

Region
Centro (IT) Toscana Pisa
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Beneficiaries (1)